-
Mashup Score: 1Connect with us - 10 month(s) ago
[BOOKMARKS] Sign up to our email bulletins We have a range of email bulletins to keep you up to date and in the loop with the latest research, news and developments in HIV. We recommend that you add the bulletin email address to your safe senders list, contacts list or address book, so that it reaches your inbox and doesn’t end up in your junk or spam folder. [SIGN_UP_FORM] Log in to our…
Source: aidsmap.comCategories: HIV/AIDS, Latest HeadlinesTweet
-
Mashup Score: 1
Antiretroviral treatment coverage in children continues to lag behind adult treatment coverage despite the implementation of ‘treat all’ guidelines, an analysis of 91 countries published in the journal Pediatrics shows. Declines in AIDS deaths in children slowed after ‘treat all’ guidelines came into effect, especially in the Asia-Pacific region, the study found.
Source: aidsmap.comCategories: HIV/AIDS, Latest HeadlinesTweet
-
Mashup Score: 2Coming soon: news from IAS 2023 - 10 month(s) ago
The 12th International AIDS Society Conference on HIV Science (IAS 2023) is taking place in Brisbane, Australia, and virtually, from 23 to 26 July. NAM aidsmap is delighted to be continuing its partnership with the International AIDS Society as an official scientific media partner for the conference. The International AIDS Society conference The IAS conference is the world’s most influential…
Source: aidsmap.comCategories: HIV/AIDS, Latest HeadlinesTweet-
#IAS2023 will feature research on: - A new case of HIV remission - Statins in people with HIV - #UequalsU - PrEP services - Human rights Find out more in our blog: https://t.co/k0arX96Pnj Sign up for our bulletins: https://t.co/IsF4eNiGBl https://t.co/BAFZJxmP6G
-
The 12th International AIDS Society Conference on HIV Science is taking place in Brisbane, Australia, and virtually, from 23-26 July. We are delighted to be continuing our partnership with @iasociety as an official scientific media partner for #IAS2023 https://t.co/k0arX96Pnj https://t.co/kYSKtLsDDt
-
-
Mashup Score: 0Who we are - 10 month(s) ago
[BOOKMARKS] Our team We are a small team of eight staff members and several freelance consultants, with a broad range of skills, expertise and experience. We are committed to bringing clear and accurate information on HIV and AIDS to those who need it and are passionate about listening to the people who use our materials to ensure they continue to be relevant, accessible and useful. Please…
Source: aidsmap.comCategories: HIV/AIDS, Latest HeadlinesTweet
-
Mashup Score: 1Trans women with HIV in South Africa far from reaching 95-95-95 targets - 10 month(s) ago
A South African study which included transgender women as core members of the research team found that the biggest gap in the HIV treatment cascade for trans women was the failure to suppress viral load among those receiving treatment. The researchers focused on trans women living in three South African cities: Johannesburg, Cape Town, and Buffalo City. Johannesburg had the highest HIV…
Source: aidsmap.comCategories: HIV/AIDS, Latest HeadlinesTweet
-
Mashup Score: 1No link between weight gain on integrase inhibitors and diabetes - 10 month(s) ago
A large Italian study demonstrates that integrase inhibitor-based antiretroviral regimens are not associated with the risk of developing type 2 diabetes. It also reveals that it is not the weight that people gain while on these drugs, but their weight when they start taking them (at baseline) which is the main factor associated with the onset of diabetes. Another study pooling previously…
Source: aidsmap.comCategories: HIV/AIDS, Latest HeadlinesTweet
-
Mashup Score: 0Coming soon: news from IAS 2023 - 10 month(s) ago
The 12th International AIDS Society Conference on HIV Science (IAS 2023) is taking place in Brisbane, Australia, and virtually, from 23 to 26 July. NAM aidsmap is delighted to be continuing its partnership with the International AIDS Society as an official scientific media partner for the conference. The International AIDS Society conference The IAS conference is the world’s most influential…
Source: aidsmap.comCategories: HIV/AIDS, Latest HeadlinesTweet
-
Mashup Score: 47
Scientists from the pharmaceutical company Merck have published the first detailed data about a subset of the familiar non-nucleoside reverse transcriptase inhibitor (NNRTI) drugs that, in addition to inhibiting HIV’s ability to copy itself, may be able to kill off HIV-infected cells by causing the virus to ‘poison’ the cells it depends on for replication.
Source: aidsmap.comCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 0Do I have to tell anyone that I have HIV? - 10 month(s) ago
Telling people that you are living with HIV can be a difficult decision to make. This page outlines some considerations regarding sharing your status.
Source: aidsmap.comCategories: HIV/AIDS, Latest HeadlinesTweet
-
Mashup Score: 2Sexual Health & HIV Policy EUROBulletin, July 2023 - 10 month(s) ago
Welcome to the July 2023 Sexual Health & HIV Policy EUROBulletin. In the feature in this edition, we hear from Nikolay Lunchenkov about the key issues in LGBT health in eastern Europe and central Asia and the challenges facing organisations there. He paints a varied picture, highlighting complex and difficult problems but also the success stories and supportive communities that inspire him.
Source: aidsmap.comCategories: HIV/AIDS, Latest HeadlinesTweet-
Other items to look out for include: a study on refugees returning to Ukraine to access reproductive healthcare; reports of steep increases in gonorrhoea diagnoses; new guidance on unexplained infertility; & a new edition of the HPV Prevention Policy Atlas https://t.co/qgFQD55MNn https://t.co/oi6DO9zo5C
-
The July Sexual Health & HIV Policy EUROBulletin is out now https://t.co/qgFQD55MNn In this edition's feature, we hear from @ECOMngo's @NikolayLunchen1 about the key issues in LGBT health in eastern Europe & central Asia & the challenges facing orgs there https://t.co/VmbJnLvc5U https://t.co/mJAnSnjCjS
-
Next week, we'll be reporting from #IAS2023, the 12th @iasociety Conference on HIV Science. As well as publishing news online, we'll be sending out five summary bulletins by email - in English, French, Spanish, Portuguese, Russian & Italian. Sign up at: https://t.co/jyYOq47ZeL https://t.co/NPN1D3cj1M